Myeloid-associated lipin-1 transcriptional co-regulatory activity is atheroprotective
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 330, 76-84
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (R01 HL131844, R01 HL 119225)
- American Heart Association (17PRE33661114)
- Louisiana State University Health Sciences Center
- National Institutes of Health
This publication has 49 references indexed in Scilit:
- Peroxisome Proliferator-Activated Receptor δ Agonist, HPP593, Prevents Renal Necrosis under Chronic IschemiaPLOS ONE, 2013
- The lipin family: mutations and metabolismCurrent Opinion in Lipidology, 2009
- Leukocyte lipid bodies — Biogenesis and functions in inflammationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Mechanisms and consequences of efferocytosis in advanced atherosclerosisJournal of Leukocyte Biology, 2009
- Lipin proteins and metabolic homeostasisJournal of Lipid Research, 2009
- CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intimaJournal of Clinical Investigation, 2008
- Alterations in Hepatic Metabolism in fld Mice Reveal a Role for Lipin 1 in Regulating VLDL-Triacylglyceride SecretionArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Peroxisome proliferator‐activated receptor‐α agonist fenofibrate regulates IL‐12 family cytokine expression in the CNS: relevance to multiple sclerosisJournal of Neurochemistry, 2007
- Matrix Metalloproteinase 2 Is Associated With Stable and Matrix Metalloproteinases 8 and 9 With Vulnerable Carotid Atherosclerotic LesionsStroke, 2006
- PPARγ and atherosclerosisCurrent Medical Research and Opinion, 2005